Wow! I just got out of bed and thought “how come the SP hasn’t budged since the Orphan Drug ANN?” Then I spotted the TH.
Well, it’s not a CR and it wouldn’t be a regular trial update. So either something has gone pear-shaped (unlikely due to previous progress) or perhaps someone has put their hand in their pocket and offered to license it?
If it was a license offer that would be great as it would provide very strong validation of the platform and provide funds that would at least delay another CR and allow in-house development of the PKD treatment.
Cheers
FHC
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.020(1.77%) |
Mkt cap ! $670.7M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.18 | $1.11 | $172.3K | 151.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 592 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 4211 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |